CN Stock MarketDetailed Quotes

600594 Guizhou Yibai Pharmaceutical

Watchlist
  • 3.88
  • +0.07+1.84%
Trading Oct 8 14:17 CST
3.07BMarket Cap-23515P/E (TTM)

Guizhou Yibai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
12.86%760.22M
12.99%770.6M
18.08%699.47M
-24.33%685.49M
-16.72%673.61M
48.05%682.01M
56.04%592.36M
26.11%905.91M
8.42%808.89M
-54.27%460.67M
Notes receivable and accounts receivable
-22.17%460.1M
-9.30%536.77M
22.29%692.32M
14.63%697.86M
-32.52%591.16M
-22.41%591.82M
-18.97%566.13M
-23.01%608.81M
4.08%876.11M
8.58%762.75M
-Notes receivable
-28.62%239.51M
-0.73%322.4M
71.30%465.26M
99.95%569.86M
-35.15%335.54M
-28.77%324.79M
-24.09%271.61M
-39.15%285M
-9.40%517.39M
5.06%455.97M
-Accounts receivable
-13.70%220.59M
-19.72%214.37M
-22.91%227.06M
-60.47%128M
-28.74%255.62M
-12.96%267.03M
-13.60%294.53M
0.46%323.81M
32.51%358.72M
14.27%306.77M
Other receivables (including interest and dividends)
-43.72%35.75M
-39.57%38.82M
-40.66%33.26M
-13.83%59.47M
55.16%63.52M
24.98%64.24M
45.90%56.05M
2.19%69.02M
-28.49%40.94M
17.20%51.4M
-Other receivable
-43.72%35.75M
----
--33.26M
----
55.16%63.52M
----
----
----
-28.49%40.94M
----
Advance payment
63.85%27.72M
232.11%55.28M
153.57%36.21M
-53.99%18.54M
-34.87%16.92M
-61.42%16.65M
4.49%14.28M
36.06%40.3M
83.31%25.98M
133.11%43.15M
Inventories
-4.47%601.39M
-1.48%614.26M
-6.15%586.65M
10.05%654.37M
5.84%629.5M
7.97%623.46M
12.70%625.08M
13.50%594.62M
14.61%594.77M
9.93%577.44M
Receivable financing
-79.49%30.78M
----
----
----
--150.1M
--148.69M
--156.1M
33.17%207.12M
----
----
Other current assets
-65.52%27.53M
-32.13%20M
-30.66%21.23M
-14.43%21.5M
296.36%79.83M
-14.11%29.46M
-12.46%30.63M
-46.48%25.12M
-48.66%20.14M
-14.00%34.3M
Total current assets
-11.84%1.94B
-5.59%2.04B
1.40%2.07B
-12.80%2.14B
-6.85%2.2B
11.74%2.16B
18.64%2.04B
5.07%2.45B
6.74%2.37B
-17.79%1.93B
Non Current assets
Other equity investment
-20.42%1.63M
-20.42%1.63M
-22.36%1.59M
-29.08%1.59M
-13.23%2.05M
-13.66%2.05M
-21.56%2.05M
-39.85%2.24M
-46.47%2.36M
-21.44%2.37M
Long-term equity investment
0.04%35.22M
-0.45%35.13M
-0.97%35.07M
-0.79%35.16M
-0.74%35.21M
-0.94%35.29M
-0.69%35.41M
-0.91%35.43M
-1.75%35.47M
-1.87%35.63M
Fixed assets
-5.28%1.64B
----
--1.71B
----
48.61%1.73B
----
----
----
-3.21%1.16B
----
Constru in process
-71.46%6.48M
----
--4.99M
----
-96.28%22.72M
----
----
----
93.83%610.86M
----
Productive biological assets
181.43%12.64M
114.17%9.23M
50.78%6.25M
20.40%4.62M
21.54%4.49M
20.79%4.31M
22.31%4.14M
23.27%3.84M
23.65%3.7M
15.83%3.57M
Intangible assets
-8.76%322.97M
-8.68%326.94M
-8.60%330.89M
-4.37%349.98M
-4.21%353.99M
-4.20%358.03M
-4.36%362.03M
2.32%365.98M
9.97%369.55M
10.01%373.73M
Goodwill
0.00%164.04M
0.00%164.04M
0.00%164.04M
-78.91%164.04M
-78.91%164.04M
-78.91%164.04M
-78.91%164.04M
23.10%777.66M
23.10%777.66M
23.10%777.66M
Long deferred expense
-15.83%111.8M
-15.91%116.87M
-15.50%123.13M
-18.07%127.21M
-18.79%132.82M
-14.67%138.99M
-14.19%145.72M
-4.32%155.26M
-5.17%163.55M
-2.81%162.87M
Deferred tax assets
-70.21%68.71M
-76.37%54.82M
18.62%55.58M
12.98%232.37M
12.10%230.64M
15.11%232.01M
48.84%46.86M
7.98%205.67M
8.36%205.75M
5.36%201.55M
Usufruct assets
-21.18%34.03M
-20.64%36.22M
3.21%38.46M
2.68%40.82M
5.10%43.17M
222.10%45.64M
148.19%37.27M
205.80%39.76M
2,076.10%41.08M
98.98%14.17M
Other non current assets
-12.73%69.53M
-0.17%67.39M
-1.20%62.42M
88.89%73.87M
2.09%79.67M
-8.39%67.5M
-12.74%63.17M
-68.63%39.11M
-46.69%78.04M
-49.33%73.68M
Total non current assets
-11.91%2.46B
-11.63%2.49B
-4.47%2.53B
-19.07%2.76B
-18.97%2.8B
-15.60%2.81B
-16.71%2.65B
10.30%3.42B
13.58%3.45B
11.27%3.33B
Total assets
-11.88%4.41B
-9.01%4.52B
-1.92%4.6B
-16.45%4.9B
-14.04%5B
-5.57%4.97B
-4.29%4.69B
8.05%5.87B
10.69%5.82B
-1.50%5.26B
Liabilities
Current liabilities
Short term loan
-25.94%426.67M
-28.61%446.01M
-16.95%446.05M
-49.15%405.96M
-29.09%576.09M
10.46%624.72M
18.19%537.11M
10.87%798.28M
44.16%812.4M
-19.84%565.55M
Notes payable and accounts payable
23.20%173.72M
20.37%182.31M
-9.62%135.06M
17.95%176.85M
-10.45%141.01M
3.02%151.46M
6.03%149.43M
21.91%149.93M
40.83%157.47M
18.82%147.02M
-Accounts payable
23.20%173.72M
20.37%182.31M
-9.62%135.06M
17.95%176.85M
-10.45%141.01M
3.02%151.46M
6.03%149.43M
21.91%149.93M
40.83%157.47M
18.82%147.02M
Contract liabilities
12.77%47.47M
-8.10%28.89M
-56.27%29.52M
-11.23%31.54M
60.15%42.1M
-43.26%31.44M
24.67%67.51M
1.19%35.53M
-45.44%26.29M
46.13%55.41M
Salaries payable
-5.13%34.57M
-5.49%34.83M
-6.36%55.99M
-11.11%49.11M
-38.90%36.44M
-22.69%36.85M
10.91%59.79M
-31.84%55.25M
-3.35%59.65M
-2.13%47.67M
Taxs payable
-32.86%34.4M
-54.58%24.92M
-55.47%28.87M
-40.80%38.3M
-12.12%51.23M
-28.19%54.86M
-17.81%64.84M
-3.58%64.69M
28.79%58.3M
3.52%76.4M
Other payable (including interest and dividends)
-42.59%77.45M
-36.96%88.09M
-5.94%103.8M
-52.50%111.86M
-56.88%134.92M
-27.54%139.75M
-32.03%110.35M
0.68%235.5M
51.14%312.9M
-4.62%192.86M
-Interest payable
-76.76%171.2K
-80.24%171.2K
-84.53%171.2K
-61.56%536.53K
-75.31%736.53K
-72.15%866.53K
-63.89%1.11M
-43.11%1.4M
10.91%2.98M
4.42%3.11M
-Other payable
-42.41%77.28M
----
--103.63M
----
-56.70%134.18M
----
----
----
51.67%309.91M
----
Non current liabilities due within one year
56.17%266.92M
53.36%261.35M
-27.03%122.85M
-52.90%99.85M
42.43%170.92M
42.01%170.42M
40.12%168.36M
180.35%211.97M
-46.91%120M
-46.67%120M
Other current liabilities
-47.39%6.05M
-41.74%6.64M
-51.42%7.45M
-18.28%9.71M
0.42%11.5M
-16.61%11.4M
5.52%15.33M
-3.66%11.89M
-14.81%11.45M
20.32%13.67M
Total current liabilities
-8.33%1.07B
-12.11%1.07B
-20.73%929.59M
-40.94%923.18M
-25.30%1.16B
0.19%1.22B
8.65%1.17B
15.94%1.56B
22.03%1.56B
-14.68%1.22B
Current liabilities
Long term loan
-29.68%238.52M
-28.62%248.42M
12.88%387.22M
36.62%442.07M
-20.70%339.19M
7.67%348.04M
8.58%343.04M
-4.36%323.59M
26.90%427.74M
32.54%323.25M
Long term account payable
759.85%85.99M
----
--87.55M
----
--10M
----
----
----
----
----
Estimate liabilities
-42.01%581.85K
-30.94%448.51K
-19.92%520.05K
--650.42K
--1M
--649.44K
--649.44K
----
----
----
Deferred tax liabilities
-6.04%33.34M
-0.01%35.62M
10.43%37.44M
9.55%32.98M
18.26%35.48M
16.37%35.62M
10.27%33.9M
4.56%30.1M
5.91%30M
11.75%30.61M
Long term deferred income
-5.15%100.86M
6.15%103.22M
6.12%106.31M
16.43%110.43M
18.37%106.34M
44.47%97.24M
48.20%100.18M
153.74%94.85M
155.51%89.84M
77.60%67.31M
Lease liabilities
-23.21%24.26M
-21.69%28.32M
3.63%30.36M
-1.69%31.78M
-12.92%31.59M
188.09%36.16M
136.03%29.3M
244.47%32.32M
--36.27M
--12.55M
Total non current liabilities
-7.65%483.55M
-2.88%502.78M
28.07%649.41M
30.33%626.71M
-10.32%523.61M
19.37%517.71M
18.84%507.07M
-1.99%480.86M
22.33%583.85M
12.79%433.72M
Total liabilities
-8.12%1.55B
-9.36%1.58B
-6.00%1.58B
-24.17%1.55B
-21.22%1.69B
5.22%1.74B
11.53%1.68B
11.16%2.04B
22.12%2.14B
-8.85%1.65B
Shareholders equity
Paid-in capital
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
Capital reserve funds
-10.90%653.84M
-10.90%653.84M
-10.90%653.84M
0.25%733.84M
0.25%733.84M
-4.22%733.84M
-4.22%733.84M
-4.41%731.99M
-4.74%731.99M
-0.29%766.15M
Surplus reserve funds
5.54%314.57M
5.54%314.57M
6.26%314.57M
0.00%298.07M
0.00%298.07M
0.00%298.07M
0.00%296.03M
0.91%298.07M
0.91%298.07M
0.91%298.07M
Retained profit
-28.42%964.7M
-16.52%1.06B
8.17%1.12B
-24.55%1.39B
-23.97%1.35B
-25.50%1.26B
-29.66%1.04B
8.22%1.84B
12.49%1.77B
7.46%1.7B
Other composite income
-30.75%684.79K
-30.75%684.79K
-34.75%645.25K
-43.12%645.25K
-19.15%988.87K
-19.74%988.87K
-16.71%988.87K
-43.98%1.13M
-41.87%1.22M
16.11%1.23M
Shareholders equity without minority interests
-14.08%2.73B
-8.83%2.82B
0.81%2.88B
-12.30%3.21B
-11.77%3.17B
-13.09%3.09B
-14.12%2.86B
3.04%3.66B
4.73%3.6B
3.44%3.55B
Minority interests
-7.31%129.33M
-8.63%130.85M
-8.26%133.81M
-12.89%137.33M
78.08%139.52M
147.88%143.21M
145.49%145.85M
368.44%157.66M
17.25%78.35M
-39.53%57.77M
Total shareholder equity
-13.80%2.86B
-8.82%2.95B
0.37%3.02B
-12.33%3.35B
-9.86%3.31B
-10.51%3.23B
-11.32%3.01B
6.46%3.82B
4.96%3.67B
2.28%3.61B
Total liabilityies and equity
-11.88%4.41B
-9.01%4.52B
-1.92%4.6B
-16.45%4.9B
-14.04%5B
-5.57%4.97B
-4.29%4.69B
8.05%5.87B
10.69%5.82B
-1.50%5.26B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
China Securities Tiantong Certified Public Accountants (Special General Partnership)
--
--
--
China Securities Tiantong Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 12.86%760.22M12.99%770.6M18.08%699.47M-24.33%685.49M-16.72%673.61M48.05%682.01M56.04%592.36M26.11%905.91M8.42%808.89M-54.27%460.67M
Notes receivable and accounts receivable -22.17%460.1M-9.30%536.77M22.29%692.32M14.63%697.86M-32.52%591.16M-22.41%591.82M-18.97%566.13M-23.01%608.81M4.08%876.11M8.58%762.75M
-Notes receivable -28.62%239.51M-0.73%322.4M71.30%465.26M99.95%569.86M-35.15%335.54M-28.77%324.79M-24.09%271.61M-39.15%285M-9.40%517.39M5.06%455.97M
-Accounts receivable -13.70%220.59M-19.72%214.37M-22.91%227.06M-60.47%128M-28.74%255.62M-12.96%267.03M-13.60%294.53M0.46%323.81M32.51%358.72M14.27%306.77M
Other receivables (including interest and dividends) -43.72%35.75M-39.57%38.82M-40.66%33.26M-13.83%59.47M55.16%63.52M24.98%64.24M45.90%56.05M2.19%69.02M-28.49%40.94M17.20%51.4M
-Other receivable -43.72%35.75M------33.26M----55.16%63.52M-------------28.49%40.94M----
Advance payment 63.85%27.72M232.11%55.28M153.57%36.21M-53.99%18.54M-34.87%16.92M-61.42%16.65M4.49%14.28M36.06%40.3M83.31%25.98M133.11%43.15M
Inventories -4.47%601.39M-1.48%614.26M-6.15%586.65M10.05%654.37M5.84%629.5M7.97%623.46M12.70%625.08M13.50%594.62M14.61%594.77M9.93%577.44M
Receivable financing -79.49%30.78M--------------150.1M--148.69M--156.1M33.17%207.12M--------
Other current assets -65.52%27.53M-32.13%20M-30.66%21.23M-14.43%21.5M296.36%79.83M-14.11%29.46M-12.46%30.63M-46.48%25.12M-48.66%20.14M-14.00%34.3M
Total current assets -11.84%1.94B-5.59%2.04B1.40%2.07B-12.80%2.14B-6.85%2.2B11.74%2.16B18.64%2.04B5.07%2.45B6.74%2.37B-17.79%1.93B
Non Current assets
Other equity investment -20.42%1.63M-20.42%1.63M-22.36%1.59M-29.08%1.59M-13.23%2.05M-13.66%2.05M-21.56%2.05M-39.85%2.24M-46.47%2.36M-21.44%2.37M
Long-term equity investment 0.04%35.22M-0.45%35.13M-0.97%35.07M-0.79%35.16M-0.74%35.21M-0.94%35.29M-0.69%35.41M-0.91%35.43M-1.75%35.47M-1.87%35.63M
Fixed assets -5.28%1.64B------1.71B----48.61%1.73B-------------3.21%1.16B----
Constru in process -71.46%6.48M------4.99M-----96.28%22.72M------------93.83%610.86M----
Productive biological assets 181.43%12.64M114.17%9.23M50.78%6.25M20.40%4.62M21.54%4.49M20.79%4.31M22.31%4.14M23.27%3.84M23.65%3.7M15.83%3.57M
Intangible assets -8.76%322.97M-8.68%326.94M-8.60%330.89M-4.37%349.98M-4.21%353.99M-4.20%358.03M-4.36%362.03M2.32%365.98M9.97%369.55M10.01%373.73M
Goodwill 0.00%164.04M0.00%164.04M0.00%164.04M-78.91%164.04M-78.91%164.04M-78.91%164.04M-78.91%164.04M23.10%777.66M23.10%777.66M23.10%777.66M
Long deferred expense -15.83%111.8M-15.91%116.87M-15.50%123.13M-18.07%127.21M-18.79%132.82M-14.67%138.99M-14.19%145.72M-4.32%155.26M-5.17%163.55M-2.81%162.87M
Deferred tax assets -70.21%68.71M-76.37%54.82M18.62%55.58M12.98%232.37M12.10%230.64M15.11%232.01M48.84%46.86M7.98%205.67M8.36%205.75M5.36%201.55M
Usufruct assets -21.18%34.03M-20.64%36.22M3.21%38.46M2.68%40.82M5.10%43.17M222.10%45.64M148.19%37.27M205.80%39.76M2,076.10%41.08M98.98%14.17M
Other non current assets -12.73%69.53M-0.17%67.39M-1.20%62.42M88.89%73.87M2.09%79.67M-8.39%67.5M-12.74%63.17M-68.63%39.11M-46.69%78.04M-49.33%73.68M
Total non current assets -11.91%2.46B-11.63%2.49B-4.47%2.53B-19.07%2.76B-18.97%2.8B-15.60%2.81B-16.71%2.65B10.30%3.42B13.58%3.45B11.27%3.33B
Total assets -11.88%4.41B-9.01%4.52B-1.92%4.6B-16.45%4.9B-14.04%5B-5.57%4.97B-4.29%4.69B8.05%5.87B10.69%5.82B-1.50%5.26B
Liabilities
Current liabilities
Short term loan -25.94%426.67M-28.61%446.01M-16.95%446.05M-49.15%405.96M-29.09%576.09M10.46%624.72M18.19%537.11M10.87%798.28M44.16%812.4M-19.84%565.55M
Notes payable and accounts payable 23.20%173.72M20.37%182.31M-9.62%135.06M17.95%176.85M-10.45%141.01M3.02%151.46M6.03%149.43M21.91%149.93M40.83%157.47M18.82%147.02M
-Accounts payable 23.20%173.72M20.37%182.31M-9.62%135.06M17.95%176.85M-10.45%141.01M3.02%151.46M6.03%149.43M21.91%149.93M40.83%157.47M18.82%147.02M
Contract liabilities 12.77%47.47M-8.10%28.89M-56.27%29.52M-11.23%31.54M60.15%42.1M-43.26%31.44M24.67%67.51M1.19%35.53M-45.44%26.29M46.13%55.41M
Salaries payable -5.13%34.57M-5.49%34.83M-6.36%55.99M-11.11%49.11M-38.90%36.44M-22.69%36.85M10.91%59.79M-31.84%55.25M-3.35%59.65M-2.13%47.67M
Taxs payable -32.86%34.4M-54.58%24.92M-55.47%28.87M-40.80%38.3M-12.12%51.23M-28.19%54.86M-17.81%64.84M-3.58%64.69M28.79%58.3M3.52%76.4M
Other payable (including interest and dividends) -42.59%77.45M-36.96%88.09M-5.94%103.8M-52.50%111.86M-56.88%134.92M-27.54%139.75M-32.03%110.35M0.68%235.5M51.14%312.9M-4.62%192.86M
-Interest payable -76.76%171.2K-80.24%171.2K-84.53%171.2K-61.56%536.53K-75.31%736.53K-72.15%866.53K-63.89%1.11M-43.11%1.4M10.91%2.98M4.42%3.11M
-Other payable -42.41%77.28M------103.63M-----56.70%134.18M------------51.67%309.91M----
Non current liabilities due within one year 56.17%266.92M53.36%261.35M-27.03%122.85M-52.90%99.85M42.43%170.92M42.01%170.42M40.12%168.36M180.35%211.97M-46.91%120M-46.67%120M
Other current liabilities -47.39%6.05M-41.74%6.64M-51.42%7.45M-18.28%9.71M0.42%11.5M-16.61%11.4M5.52%15.33M-3.66%11.89M-14.81%11.45M20.32%13.67M
Total current liabilities -8.33%1.07B-12.11%1.07B-20.73%929.59M-40.94%923.18M-25.30%1.16B0.19%1.22B8.65%1.17B15.94%1.56B22.03%1.56B-14.68%1.22B
Current liabilities
Long term loan -29.68%238.52M-28.62%248.42M12.88%387.22M36.62%442.07M-20.70%339.19M7.67%348.04M8.58%343.04M-4.36%323.59M26.90%427.74M32.54%323.25M
Long term account payable 759.85%85.99M------87.55M------10M--------------------
Estimate liabilities -42.01%581.85K-30.94%448.51K-19.92%520.05K--650.42K--1M--649.44K--649.44K------------
Deferred tax liabilities -6.04%33.34M-0.01%35.62M10.43%37.44M9.55%32.98M18.26%35.48M16.37%35.62M10.27%33.9M4.56%30.1M5.91%30M11.75%30.61M
Long term deferred income -5.15%100.86M6.15%103.22M6.12%106.31M16.43%110.43M18.37%106.34M44.47%97.24M48.20%100.18M153.74%94.85M155.51%89.84M77.60%67.31M
Lease liabilities -23.21%24.26M-21.69%28.32M3.63%30.36M-1.69%31.78M-12.92%31.59M188.09%36.16M136.03%29.3M244.47%32.32M--36.27M--12.55M
Total non current liabilities -7.65%483.55M-2.88%502.78M28.07%649.41M30.33%626.71M-10.32%523.61M19.37%517.71M18.84%507.07M-1.99%480.86M22.33%583.85M12.79%433.72M
Total liabilities -8.12%1.55B-9.36%1.58B-6.00%1.58B-24.17%1.55B-21.22%1.69B5.22%1.74B11.53%1.68B11.16%2.04B22.12%2.14B-8.85%1.65B
Shareholders equity
Paid-in capital 0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M
Capital reserve funds -10.90%653.84M-10.90%653.84M-10.90%653.84M0.25%733.84M0.25%733.84M-4.22%733.84M-4.22%733.84M-4.41%731.99M-4.74%731.99M-0.29%766.15M
Surplus reserve funds 5.54%314.57M5.54%314.57M6.26%314.57M0.00%298.07M0.00%298.07M0.00%298.07M0.00%296.03M0.91%298.07M0.91%298.07M0.91%298.07M
Retained profit -28.42%964.7M-16.52%1.06B8.17%1.12B-24.55%1.39B-23.97%1.35B-25.50%1.26B-29.66%1.04B8.22%1.84B12.49%1.77B7.46%1.7B
Other composite income -30.75%684.79K-30.75%684.79K-34.75%645.25K-43.12%645.25K-19.15%988.87K-19.74%988.87K-16.71%988.87K-43.98%1.13M-41.87%1.22M16.11%1.23M
Shareholders equity without minority interests -14.08%2.73B-8.83%2.82B0.81%2.88B-12.30%3.21B-11.77%3.17B-13.09%3.09B-14.12%2.86B3.04%3.66B4.73%3.6B3.44%3.55B
Minority interests -7.31%129.33M-8.63%130.85M-8.26%133.81M-12.89%137.33M78.08%139.52M147.88%143.21M145.49%145.85M368.44%157.66M17.25%78.35M-39.53%57.77M
Total shareholder equity -13.80%2.86B-8.82%2.95B0.37%3.02B-12.33%3.35B-9.86%3.31B-10.51%3.23B-11.32%3.01B6.46%3.82B4.96%3.67B2.28%3.61B
Total liabilityies and equity -11.88%4.41B-9.01%4.52B-1.92%4.6B-16.45%4.9B-14.04%5B-5.57%4.97B-4.29%4.69B8.05%5.87B10.69%5.82B-1.50%5.26B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion with explanatory notes------Unqualified opinion------
Auditor ----China Securities Tiantong Certified Public Accountants (Special General Partnership)------China Securities Tiantong Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data